Cargando…

Neuromuscular blockade management in the critically Ill patient

Neuromuscular blocking agents (NMBAs) can be an effective modality to address challenges that arise daily in the intensive care unit (ICU). These medications are often used to optimize mechanical ventilation, facilitate endotracheal intubation, stop overt shivering during therapeutic hypothermia fol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renew, J. Ross, Ratzlaff, Robert, Hernandez-Torres, Vivian, Brull, Sorin J., Prielipp, Richard C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245849/ https://www.ncbi.nlm.nih.gov/pubmed/32483489 http://dx.doi.org/10.1186/s40560-020-00455-2

Ejemplares similares

Neuromuscular blockade management in patients with COVID-19
por: Chaves-Cardona, Harold, et al.
Publicado: (2021)

An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
por: Paredes, Stephania, et al.
Publicado: (2023)

Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Paredes, Stephania, et al.
Publicado: (2023)

Comparison of onset of neuromuscular blockade with electromyographic and acceleromyographic monitoring: a prospective clinical trial
por: Chaves-Cardona, Harold E., et al.
Publicado: (2023)

Preparing for the unexpected: special considerations and complications after sugammadex administration
por: Iwasaki, Hajime, et al.
Publicado: (2017)

Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients.
por: Prielipp, R. C.
Publicado: (1998)

Neuromuscular blockade in the elderly patient
por: Lee, Luis A, et al.
Publicado: (2016)

Validation of a convolutional neural network that reliably identifies electromyographic compound motor action potentials following train-of-four stimulation: an algorithm development experimental study()
por: Epstein, Richard H., et al.
Publicado: (2023)

Detrimental Effects of Filling Laryngotracheal Airways To Excessive Pressure (DEFLATE-P): a quality improvement initiative
por: Fritz, Ashley V., et al.
Publicado: (2020)

Neuromuscular blockade administration is associated with altered energy expenditure in critically ill intubated patients with COVID-19
por: Karayiannis, D., et al.
Publicado: (2022)

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction
por: de Boer, Hans D, et al.
Publicado: (2018)

Intraoperative Monitoring of Neuromuscular Blockade
por: Motamed, Cyrus
Publicado: (2023)

A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU
por: Bologheanu, Răzvan, et al.
Publicado: (2022)

Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
por: Stout, Robert G., et al.
Publicado: (2004)

Acquired neuromuscular disorders in critically ill patients: a systematic review
por: De Jonghe, B., et al.
Publicado: (1998)

Novel drug development for neuromuscular blockade
por: Prabhakar, Amit, et al.
Publicado: (2016)

Feasibility of neuromuscular electrical stimulation in critically ill patients
por: Segers, J, et al.
Publicado: (2013)

Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients
por: Tsolaki, Vasiliki, et al.
Publicado: (2022)

The Use of a Novel Endotracheal Tube and Airway Management System to Prevent Complications in Lung Transplantation
por: Hernandez-Torres, Vivian, et al.
Publicado: (2019)

Monitoring of neuromuscular function in the clinical setting.
por: Kelly, D., et al.
Publicado: (1993)

Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021)

Neuromuscular involvement in COVID-19 critically ill patients
por: Cabañes-Martínez, Lidia, et al.
Publicado: (2020)

Safety of neuromuscular electrical stimulation among critically ill patients: systematic review
por: Sachetti, Amanda, et al.
Publicado: (2018)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
por: Gonçalves, Pedro Marcos Silva e, et al.
Publicado: (2020)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade
por: Luo, Jie, et al.
Publicado: (2018)

Differential contractile response of critically ill patients to neuromuscular electrical stimulation
por: Grunow, Julius J., et al.
Publicado: (2019)

Improved oxygenation after discontinuing neuromuscular blockade
por: Willson, D. F., et al.
Publicado: (1997)

Neuromuscular electrical stimulation in critically ill patients in the intensive care unit: a systematic review
por: Ferreira, Lucas Lima, et al.
Publicado: (2014)

In response: Interdisciplinary intraoperative communication and collaboration needed for optimal neuromuscular blockade management
por: Answine, Joseph F, et al.
Publicado: (2014)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Interdisciplinary intraoperative communication and collaboration needed for optimal neuromuscular blockade management
por: Welliver, Mark D., et al.
Publicado: (2014)

Current Trends in Neuromuscular Blockade, Management, and Monitoring amongst Singaporean Anaesthetists
por: Teoh, Wendy H., et al.
Publicado: (2016)

A surgeon’s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
por: Lamberg, James J, et al.
Publicado: (2013)

Management of Patients with the Intravascular Ventricular Assist System (iVAS) for Non-Cardiac Surgery
por: Karuppiah, Sathappan, et al.
Publicado: (2022)

Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study
por: Bouju, Pierre, et al.
Publicado: (2017)

Asystole Following Neuromuscular Blockade Reversal in Cardiac Transplant Patients
por: Nkemngu, Njinkeng J
Publicado: (2017)

Neuromuscular blockade in patients with ARDS: a rapid practice guideline
por: Alhazzani, Waleed, et al.
Publicado: (2020)

Estimation of the diaphragm neuromuscular efficiency index in mechanically ventilated critically ill patients
por: Jansen, Diana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eu5tnvbj9fg641e6hbj0ooep4f